Sequential sorafenib and sunitinib for renal cell carcinoma. [electronic resource]
Producer: 20100701Description: 29-34; discussion 34 p. digitalISSN:- 1527-3792
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzenesulfonates -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Cohort Studies
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Interactions
- Female
- Follow-Up Studies
- Humans
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Metastasis
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Probability
- Pyridines -- administration & dosage
- Pyrroles -- administration & dosage
- Retrospective Studies
- Risk Assessment
- Sorafenib
- Sunitinib
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.